4.7 Article

Understanding the increased risk of infections in diabetes: innate and adaptive immune responses in type 1 diabetes

Journal

METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 121, Issue -, Pages -

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.metabol.2021.154795

Keywords

Adaptive immune system; Cytokine response; Infections; Innate immune system; Type 1 diabetes

Funding

  1. Perspectief Biomarker Development Center Research Programme - Netherlands Organisation for Scientific Research (NWO)
  2. European Foundation for the Study of Diabetes (EFSD/AZ Macrovascular Programme 2015)
  3. European Union Horizon 2020 research and innovation program REPROGRAM [667837]
  4. Netherlands Organization for Scientific Research Spinoza Grant [NWO SPI 94212]
  5. ERC [833247]
  6. Competitiveness Operational Programme grant of the Romanian Ministry of European Funds [P_37_762, MySMIS 103587]
  7. Dutch Heart Foundation [2018T093, CVON2012-03, CVON201827]
  8. Dutch Diabetes Foundation
  9. TIMID Consortium: new taxonomy and treatment strategies for T cell driven Immune Mediated Inflammatory Diseases [LSHM18057SGF]
  10. ERA-CVD Joint Transnational Call 2018

Ask authors/readers for more resources

Patients with type 1 diabetes demonstrate significantly lower cytokine production in response to stimulation with various pathogens, which may partly explain their increased susceptibility to infections. Shorter duration of diabetes and older age are associated with decreased cytokine production after pathogenic stimulation.
Aims: Patients with diabetes have a higher incidence of infections with Candida albicans, Staphylococcus aureus and Mycobacterium tuberculosis, yet factors contributing to this increased risk are largely unknown. We hypothesize that altered innate and adaptive immune responses during diabetes contribute to an increased susceptibility to infections. Materials and methods: We studied cytokine responses to ex vivo pathogenic stimulations in a cohort with type 1 diabetes (n = 243) and non-diabetic healthy control subjects (n = 56) using isolated peripheral blood mononuclear cells (PBMCs). Clinical phenotypical data including BMI, duration of diabetes, and HbA(1c) levels were collected and related to the cytokine production capacity. Results: Adjusted for age, sex and BMI, the presence of diabetes was associated with significantly lower IL-1 beta, IL-6, TNF-alpha, and IL-17 production upon ex vivo stimulation of PBMCs with C. albicans and S. aureus (all, p < 0.05). In response to stimulation with M. tuberculosis only IL-17 (p < 0.001) was lower in patients with diabetes. Patients with the shortest diabetes duration had a significant lower IL-1 beta, IL-6 and TNF-alpha production (all, p < 0.01) after M. tuberculosis stimulation. Older patients had a significant lower IFN-gamma (p < 0.05) production after stimulation with all three pathogens. HbA(1c) levels and BMI had no significant impact on cytokine production. Conclusions: PBMCs of patients with type 1 diabetes demonstrate significantly lower cytokine production in response to stimulation with several pathogens, which likely explain, at least in part, the increased susceptibility for these infections. (C) 2021 Published by Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available